HYDROCORTISONE CREAM

HYDROCORTISONE CREAM was reported 68550 times

HYDROCORTISONE CREAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 113 0.5979
1 VAGINAL FLATULENCE 138 0.4554
2 LYMPHOID TISSUE HYPOPLASIA 68 0.4444
3 THYMUS HYPOPLASIA 73 0.4195
4 C-REACTIVE PROTEIN 353 0.3808
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 754 0.3764
6 GRIP STRENGTH 86 0.3755
7 TOPICAL STEROID WITHDRAWAL REACTION 146 0.3753
8 LUPUS VULGARIS 456 0.3619
9 RHEUMATIC FEVER 1547 0.3467
10 SWOLLEN JOINT COUNT INCREASED 1089 0.3412
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 225 0.3368
12 FACET JOINT SYNDROME 1069 0.3280
13 SWOLLEN JOINT COUNT 72 0.2880
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 592 0.2854
15 CYSTITIS BACTERIAL 96 0.2840
16 NOROVIRUS TEST POSITIVE 88 0.2708
17 DISLOCATION OF VERTEBRA 579 0.2536
18 DUODENAL ULCER PERFORATION 1885 0.2532
19 X-RAY ABNORMAL 452 0.2525
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1785 0.2489
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 139 0.2478
22 STEROID DEPENDENCE 216 0.2460
23 RHEUMATOID FACTOR POSITIVE 1395 0.2413
24 STEROID WITHDRAWAL SYNDROME 243 0.2378
25 CRANIOPHARYNGIOMA 74 0.2229
26 ADRENOCORTICAL INSUFFICIENCY ACUTE 426 0.2181
27 MYCOBACTERIUM CHELONAE INFECTION 155 0.2097
28 RETINITIS 362 0.2094
29 APPENDICOLITH 79 0.2041
30 ANALGESIC THERAPY 63 0.1963
31 HYPOCHOLESTEROLAEMIA 69 0.1955
32 PERIPHERAL VENOUS DISEASE 782 0.1913
33 SECONDARY IMMUNODEFICIENCY 229 0.1885
34 CATARRH 169 0.1869
35 ABSCESS BACTERIAL 66 0.1818
36 HELICOBACTER INFECTION 1865 0.1813
37 ADRENAL SUPPRESSION 149 0.1767
38 PEMPHIGUS 2059 0.1645
39 C-REACTIVE PROTEIN ABNORMAL 1036 0.1613
40 PORPHYRIA ACUTE 230 0.1603
41 MUSCLE INJURY 1300 0.1567
42 HAND DEFORMITY 2014 0.1534
43 FOLLICULITIS 1537 0.1464
44 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 934 0.1437
45 CORONA VIRUS INFECTION 60 0.1395
46 OVERLAP SYNDROME 96 0.1371
47 HYPOFIBRINOGENAEMIA 128 0.1290
48 BREAST CANCER STAGE III 832 0.1283
49 PERICARDITIS 2059 0.1224
50 SYNOVITIS 2098 0.1162
51 LIP DRY 1036 0.1139
52 PSEUDOMONAL SEPSIS 197 0.1124
53 SERONEGATIVE ARTHRITIS 125 0.1091
54 ONYCHOMADESIS 454 0.1081
55 DRUG TOLERANCE DECREASED 299 0.1064
56 FEMALE GENITAL TRACT FISTULA 181 0.1059
57 PARAINFLUENZAE VIRUS INFECTION 150 0.0985
58 FEBRILE BONE MARROW APLASIA 410 0.0964
59 GRIP STRENGTH DECREASED 840 0.0953
60 ONYCHOMYCOSIS 418 0.0952
61 GLOSSODYNIA 2112 0.0942
62 HYPERCHOLESTEROLAEMIA 910 0.0942
63 BURNS SECOND DEGREE 165 0.0940
64 JOINT RANGE OF MOTION DECREASED 1250 0.0931
65 LIVE BIRTH 765 0.0914
66 HUMAN HERPESVIRUS 6 INFECTION 168 0.0888
67 BONE EROSION 309 0.0873
68 BURSITIS 1040 0.0856
69 WOUND INFECTION 937 0.0855
70 SECONDARY ADRENOCORTICAL INSUFFICIENCY 124 0.0821
71 GRAFT LOSS 59 0.0814
72 DEATH NEONATAL 113 0.0812
73 WOUND 2222 0.0794
74 ENTEROBACTER INFECTION 133 0.0791
75 ADRENAL INSUFFICIENCY 941 0.0775
76 BLEPHAROSPASM 483 0.0766
77 AUTOIMMUNE DISORDER 736 0.0754
78 RADICULOPATHY 188 0.0713
79 IRRITABLE BOWEL SYNDROME 1509 0.0703
80 BODY TEMPERATURE FLUCTUATION 146 0.0700
81 SYSTEMIC LUPUS ERYTHEMATOSUS 2438 0.0686
82 FIBROMYALGIA 1651 0.0678
83 VIRAEMIA 93 0.0671
84 PROCTITIS 184 0.0656
85 DIABETES INSIPIDUS 158 0.0656
86 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
87 DRUG LEVEL BELOW THERAPEUTIC 356 0.0645
88 CHRONIC SINUSITIS 238 0.0633
89 PITUITARY TUMOUR BENIGN 99 0.0607
90 TYPE 2 DIABETES MELLITUS 1946 0.0577
91 LIVER INJURY 1374 0.0559
92 NAIL DISORDER 483 0.0551
93 HYPOPITUITARISM 96 0.0551
94 SKIN WEEPING 195 0.0546
95 CORTISOL DECREASED 62 0.0542
96 CYTOMEGALOVIRUS CHORIORETINITIS 105 0.0538
97 OBESITY 849 0.0532
98 INFUSION RELATED REACTION 3504 0.0528
99 FINGER DEFORMITY 256 0.0528
100 SCIATICA 840 0.0526
101 CONTRAINDICATED PRODUCT ADMINISTERED 1595 0.0526
102 PRODUCT LABEL CONFUSION 305 0.0523
103 FAECAL CALPROTECTIN INCREASED 165 0.0521
104 MATERNAL EXPOSURE TIMING UNSPECIFIED 193 0.0513
105 HYPOPNOEA 174 0.0501
106 BRONCHIECTASIS 332 0.0492
107 IMPAIRED HEALING 1606 0.0489
108 RHINOVIRUS INFECTION 190 0.0488
109 HYPOPHYSITIS 98 0.0487
110 PNEUMATOSIS INTESTINALIS 137 0.0480
111 PUSTULAR PSORIASIS 164 0.0477
112 GASTROENTERITIS NOROVIRUS 63 0.0474
113 PULMONARY FIBROSIS 904 0.0471
114 EXOSTOSIS 428 0.0468
115 BLOOD PRESSURE FLUCTUATION 1088 0.0453
116 ULCER HAEMORRHAGE 304 0.0449
117 PSORIATIC ARTHROPATHY 1816 0.0447
118 LOWER LIMB FRACTURE 834 0.0434
119 ANAL FISSURE 232 0.0432
120 EYE INJURY 131 0.0431
121 ADRENAL DISORDER 82 0.0427
122 APLASTIC ANAEMIA 222 0.0425
123 STRONGYLOIDIASIS 68 0.0421
124 PRESCRIBED OVERDOSE 810 0.0418
125 WALKING AID USER 275 0.0417
126 CONGENITAL ANOMALY 316 0.0408
127 INTENTIONAL PRODUCT USE ISSUE 3540 0.0404
128 LOWER RESPIRATORY TRACT INFECTION 1830 0.0402
129 ALCOHOL POISONING 106 0.0395
130 LUPUS-LIKE SYNDROME 358 0.0394
131 NORMAL NEWBORN 214 0.0393
132 COELIAC DISEASE 386 0.0393
133 BLOOD CHOLESTEROL INCREASED 1811 0.0388
134 RASH VESICULAR 187 0.0386
135 BREAST CANCER STAGE II 315 0.0378
136 CUSHINGOID 121 0.0377
137 DRUG LEVEL ABOVE THERAPEUTIC 170 0.0371
138 HYPERPHOSPHATAEMIA 79 0.0367
139 RED BLOOD CELL SEDIMENTATION RATE INCREASED 405 0.0366
140 ARTHROPATHY 2027 0.0364
141 GAIT INABILITY 1203 0.0360
142 BACK INJURY 388 0.0356
143 BLOOD PRESSURE DIASTOLIC DECREASED 259 0.0351
144 BRONCHOPULMONARY ASPERGILLOSIS 271 0.0349
145 BLISTER 1953 0.0347
146 PRESCRIBED UNDERDOSE 681 0.0341
147 SERUM SICKNESS 95 0.0341
148 BLOOD PHOSPHORUS INCREASED 92 0.0337
149 HEPATIC ENZYME INCREASED 2261 0.0331
150 ASPERGILLUS INFECTION 216 0.0329
151 POOR VENOUS ACCESS 335 0.0323
152 LEUKOENCEPHALOPATHY 120 0.0322
153 CLOSTRIDIUM DIFFICILE COLITIS 341 0.0321
154 THERAPEUTIC PRODUCT EFFECT DECREASED 1423 0.0317
155 MYELOPATHY 60 0.0316
156 HYPERTRIGLYCERIDAEMIA 184 0.0314
157 FOOT DEFORMITY 348 0.0314
158 DRUG SPECIFIC ANTIBODY PRESENT 204 0.0313
159 FREQUENT BOWEL MOVEMENTS 842 0.0311
160 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 531 0.0309
161 DISCOMFORT 1884 0.0308
162 ERYTHEMA NODOSUM 108 0.0307
163 NIGHT SWEATS 989 0.0307
164 STOMATITIS 1859 0.0306
165 WHEEZING 1817 0.0306
166 HIP ARTHROPLASTY 467 0.0305
167 JOINT DISLOCATION 318 0.0301
168 DRUG LEVEL DECREASED 299 0.0293
169 ESCHERICHIA BACTERAEMIA 69 0.0293
170 C-REACTIVE PROTEIN INCREASED 1060 0.0291
171 OSTEOARTHRITIS 1232 0.0290
172 TEMPERATURE REGULATION DISORDER 64 0.0287
173 KOUNIS SYNDROME 65 0.0286
174 ENTERITIS 183 0.0286
175 INFUSION SITE REACTION 85 0.0284
176 CYTOMEGALOVIRUS VIRAEMIA 126 0.0283
177 GINGIVAL PAIN 222 0.0279
178 SPONDYLITIS 101 0.0277
179 BACTERIAL INFECTION 515 0.0276
180 OESOPHAGEAL CANDIDIASIS 110 0.0276
181 APHTHOUS ULCER 212 0.0273
182 SWELLING 2528 0.0270
183 BLOOD PRESSURE DIASTOLIC INCREASED 124 0.0268
184 KLEBSIELLA INFECTION 135 0.0267
185 INFLAMMATION 1364 0.0264
186 HYPERCAPNIA 78 0.0259
187 SYSTEMIC CANDIDA 65 0.0259
188 RHINITIS 208 0.0258
189 OEDEMA 1383 0.0255
190 MOBILITY DECREASED 1829 0.0254
191 BLOOD CULTURE POSITIVE 76 0.0254
192 HYPERNATRAEMIA 126 0.0253
193 TASTE DISORDER 512 0.0252
194 MATERNAL EXPOSURE DURING PREGNANCY 2246 0.0252
195 STAPHYLOCOCCAL SEPSIS 124 0.0251
196 VENOUS THROMBOSIS 98 0.0249
197 LARGE INTESTINAL ULCER 66 0.0243
198 OXYGEN SATURATION ABNORMAL 69 0.0243
199 ROAD TRAFFIC ACCIDENT 1017 0.0243
200 INJURY 1706 0.0242
201 ENTEROCOCCAL INFECTION 117 0.0242
202 BODY TEMPERATURE DECREASED 238 0.0242
203 EPILEPSY 728 0.0238
204 COLITIS ULCERATIVE 1063 0.0238
205 ORAL CANDIDIASIS 312 0.0237
206 DRUG INTOLERANCE 2288 0.0237
207 IRON DEFICIENCY 105 0.0233
208 CARDIAC MURMUR 202 0.0233
209 SLEEP DISORDER 1647 0.0233
210 PAROSMIA 175 0.0232
211 MUCOSAL INFLAMMATION 604 0.0230
212 MYOSITIS 207 0.0230
213 WEIGHT FLUCTUATION 241 0.0230
214 LUNG DISORDER 1124 0.0229
215 NEUTROPENIC SEPSIS 162 0.0227
216 FEBRILE NEUTROPENIA 1504 0.0226
217 HYPOPHOSPHATAEMIA 166 0.0224
218 LIVER FUNCTION TEST INCREASED 475 0.0221
219 GENERAL PHYSICAL HEALTH DETERIORATION 2545 0.0220
220 MUSCULOSKELETAL STIFFNESS 1920 0.0219
221 ADVERSE REACTION 290 0.0218
222 ILL-DEFINED DISORDER 1323 0.0218
223 IMPAIRED QUALITY OF LIFE 313 0.0217
224 ESCHERICHIA SEPSIS 63 0.0217
225 KNEE ARTHROPLASTY 457 0.0217
226 DELIRIUM 752 0.0216
227 BACTERIAL SEPSIS 70 0.0215
228 HEART RATE DECREASED 751 0.0214
229 DRUG-INDUCED LIVER INJURY 667 0.0212
230 JOINT SWELLING 2537 0.0210
231 TREATMENT FAILURE 1740 0.0210
232 EXPOSURE DURING PREGNANCY 1305 0.0210
233 NEOPLASM RECURRENCE 71 0.0209
234 RHEUMATOID ARTHRITIS 2376 0.0209
235 DERMATITIS EXFOLIATIVE GENERALISED 72 0.0207
236 RECTAL HAEMORRHAGE 887 0.0206
237 GRAFT VERSUS HOST DISEASE 148 0.0206
238 THERAPY NON-RESPONDER 924 0.0205
239 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 104 0.0205
240 ANAL FISTULA 109 0.0204
241 INFUSION SITE EXTRAVASATION 127 0.0204
242 SKIN ATROPHY 116 0.0201
243 HERPES SIMPLEX 131 0.0201
244 LIVER DISORDER 892 0.0201
245 MUSCULOSKELETAL PAIN 1050 0.0200
246 GROWTH RETARDATION 59 0.0200
247 HEPATIC CIRRHOSIS 373 0.0198
248 SUSPECTED OFF LABEL USE 89 0.0197
249 SEPTIC SHOCK 842 0.0193
250 RESPIRATORY ACIDOSIS 76 0.0193
251 BLOOD PRESSURE SYSTOLIC INCREASED 377 0.0193
252 FISTULA 217 0.0193
253 PROCTALGIA 124 0.0193
254 EAR INFECTION 513 0.0193
255 GENERAL SYMPTOM 144 0.0192
256 VAGINAL DISCHARGE 193 0.0191
257 PSEUDOMONAS INFECTION 163 0.0190
258 HEART RATE IRREGULAR 428 0.0189
259 RESPIRATORY RATE INCREASED 167 0.0188
260 MULTIPLE ORGAN DYSFUNCTION SYNDROME 530 0.0187
261 DRY MOUTH 1517 0.0187
262 EAR PAIN 362 0.0186
263 CONDITION AGGRAVATED 5569 0.0183
264 MUCOUS STOOLS 90 0.0182
265 HYPOALBUMINAEMIA 141 0.0181
266 GASTROINTESTINAL DISORDER 1622 0.0181
267 HYPERTRANSAMINASAEMIA 124 0.0178
268 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 170 0.0178
269 STAPHYLOCOCCAL BACTERAEMIA 77 0.0177
270 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 295 0.0174
271 BLOOD URIC ACID INCREASED 100 0.0173
272 AORTIC STENOSIS 60 0.0172
273 VENOOCCLUSIVE LIVER DISEASE 84 0.0170
274 ABDOMINAL DISCOMFORT 2853 0.0170
275 BACTERAEMIA 200 0.0168
276 PARAESTHESIA ORAL 243 0.0168
277 DYSPEPSIA 1657 0.0168
278 SINUSITIS 1726 0.0168
279 NEPHROGENIC ANAEMIA 77 0.0166
280 RED CELL DISTRIBUTION WIDTH INCREASED 69 0.0166
281 RALES 96 0.0165
282 MIGRAINE 1578 0.0165
283 SPINAL FUSION SURGERY 67 0.0165
284 CANDIDA INFECTION 278 0.0164
285 PNEUMOCYSTIS JIROVECII PNEUMONIA 165 0.0164
286 HYPERBILIRUBINAEMIA 169 0.0163
287 RESPIRATORY DISORDER 488 0.0163
288 ANAL ABSCESS 87 0.0161
289 SKIN INFECTION 179 0.0159
290 TOXIC EPIDERMAL NECROLYSIS 242 0.0159
291 JOINT STIFFNESS 418 0.0159
292 APPENDICITIS 148 0.0158
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 758 0.0158
294 CONTUSION 1513 0.0157
295 BODY TEMPERATURE INCREASED 319 0.0156
296 WOUND SECRETION 61 0.0156
297 OSTEOPOROSIS 638 0.0155
298 PAPULE 109 0.0155
299 URTICARIA 2586 0.0154
300 COLITIS 583 0.0154
301 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1079 0.0152
302 HYPERSENSITIVITY 2803 0.0151
303 CARDIOGENIC SHOCK 216 0.0150
304 ECZEMA 780 0.0149
305 ENCEPHALITIS 103 0.0149
306 DISABILITY 292 0.0148
307 UVEITIS 200 0.0147
308 HYPERTENSION 3117 0.0147
309 TUMOUR LYSIS SYNDROME 129 0.0146
310 HEPATITIS 372 0.0145
311 CONFUSIONAL STATE 2328 0.0144
312 PREGNANCY 287 0.0143
313 HYPOAESTHESIA 2124 0.0142
314 HYDROCEPHALUS 77 0.0141
315 VIRAL INFECTION 468 0.0140
316 SKIN PLAQUE 118 0.0140
317 ATELECTASIS 135 0.0140
318 SKIN WARM 81 0.0139
319 INFECTION 2002 0.0138
320 ALOPECIA 2703 0.0137
321 HYPONATRAEMIA 775 0.0137
322 ABSCESS 219 0.0137
323 HAEMATOCHEZIA 757 0.0137
324 ORAL DISORDER 100 0.0136
325 BACK DISORDER 221 0.0136
326 ARTERIOSCLEROSIS CORONARY ARTERY 90 0.0136
327 MACULAR DEGENERATION 162 0.0136
328 CLOSTRIDIUM DIFFICILE INFECTION 296 0.0135
329 BENIGN PROSTATIC HYPERPLASIA 70 0.0135
330 TUBULOINTERSTITIAL NEPHRITIS 254 0.0135
331 HYPOKALAEMIA 624 0.0135
332 POLYARTHRITIS 71 0.0135
333 BLOOD THYROID STIMULATING HORMONE DECREASED 61 0.0134
334 VENTRICULAR FIBRILLATION 149 0.0134
335 ACUTE RESPIRATORY DISTRESS SYNDROME 237 0.0134
336 WEIGHT INCREASED 2996 0.0134
337 ARTHRITIS INFECTIVE 62 0.0134
338 MEDICATION ERROR 741 0.0133
339 NEURALGIA 322 0.0132
340 VASCULAR DEVICE INFECTION 60 0.0132
341 THERAPEUTIC RESPONSE SHORTENED 437 0.0132
342 VAGINAL INFECTION 61 0.0129
343 HYPOVOLAEMIC SHOCK 62 0.0129
344 PERIPHERAL SWELLING 1970 0.0128
345 NASOPHARYNGITIS 2351 0.0127
346 FAILURE TO THRIVE 66 0.0127
347 DEFAECATION URGENCY 89 0.0127
348 INFLAMMATORY MARKER INCREASED 62 0.0125
349 DRUG LEVEL INCREASED 206 0.0124
350 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2233 0.0124
351 MYASTHENIA GRAVIS 100 0.0124
352 INFUSION SITE SWELLING 77 0.0122
353 PRODUCT USE ISSUE 2289 0.0122
354 SEPSIS 1340 0.0120
355 ENDOCARDITIS 61 0.0119
356 OXYGEN SATURATION DECREASED 663 0.0118
357 ACIDOSIS 90 0.0118
358 PYREXIA 4061 0.0117
359 HYPERLIPIDAEMIA 140 0.0117
360 TROPONIN INCREASED 89 0.0117
361 DRUG TOLERANCE 59 0.0117
362 RASH 5059 0.0116
363 BLOOD LACTIC ACID INCREASED 61 0.0116
364 HAEMODYNAMIC INSTABILITY 88 0.0115
365 HAEMORRHOIDS 225 0.0115
366 RESPIRATORY DISTRESS 318 0.0115
367 SKIN LESION 316 0.0115
368 STREPTOCOCCAL INFECTION 64 0.0115
369 ASTHMA 1294 0.0114
370 INFUSION SITE PAIN 147 0.0114
371 SKIN SWELLING 99 0.0114
372 UPPER RESPIRATORY TRACT INFECTION 527 0.0114
373 AMNESIA 740 0.0114
374 DIARRHOEA HAEMORRHAGIC 106 0.0113
375 TACHYPNOEA 154 0.0113
376 TENDERNESS 118 0.0113
377 TACHYCARDIA 1005 0.0113
378 SKIN HYPERPIGMENTATION 97 0.0113
379 ARTHRITIS 886 0.0113
380 PULMONARY HAEMORRHAGE 88 0.0112
381 ACUTE RESPIRATORY FAILURE 216 0.0112
382 LUNG INFILTRATION 99 0.0112
383 NEUROTOXICITY 196 0.0112
384 MOUTH ULCERATION 235 0.0111
385 RASH PRURITIC 604 0.0111
386 ENCEPHALOPATHY 273 0.0111
387 ENTEROCOLITIS 64 0.0111
388 PRODUCT ADMINISTRATION INTERRUPTED 87 0.0111
389 OFF LABEL USE 9693 0.0111
390 CYTOKINE RELEASE SYNDROME 222 0.0111
391 ORAL HERPES 216 0.0111
392 OBSTRUCTIVE AIRWAYS DISORDER 123 0.0110
393 HYPERGLYCAEMIA 401 0.0110
394 PRODUCT USE IN UNAPPROVED INDICATION 2725 0.0110
395 THROMBOTIC MICROANGIOPATHY 107 0.0110
396 ANAPHYLACTIC REACTION 606 0.0110
397 IMPAIRED WORK ABILITY 234 0.0109
398 ESCHERICHIA INFECTION 90 0.0109
399 DISSEMINATED INTRAVASCULAR COAGULATION 154 0.0109
400 SKIN FISSURES 213 0.0109
401 POLYURIA 89 0.0109
402 NECK PAIN 606 0.0108
403 DERMATITIS 227 0.0108
404 GASTROENTERITIS 158 0.0108
405 SWOLLEN TONGUE 337 0.0108
406 HYDRONEPHROSIS 80 0.0107
407 HYPOXIA 374 0.0106
408 STAPHYLOCOCCAL INFECTION 350 0.0106
409 MULTI-ORGAN FAILURE 183 0.0106
410 MOUTH SWELLING 61 0.0106
411 ARTHRALGIA 4394 0.0106
412 APPETITE DISORDER 70 0.0105
413 CONCOMITANT DISEASE AGGRAVATED 65 0.0105
414 GASTROOESOPHAGEAL REFLUX DISEASE 843 0.0105
415 MALNUTRITION 117 0.0104
416 LIPASE INCREASED 80 0.0104
417 SKIN LACERATION 113 0.0104
418 BLOOD PRESSURE INCREASED 1588 0.0104
419 FEELING HOT 635 0.0103
420 CYTOMEGALOVIRUS INFECTION 172 0.0103
421 NEUROLOGICAL SYMPTOM 59 0.0103
422 RESPIRATORY FAILURE 751 0.0103
423 PALLOR 280 0.0103
424 LOWER GASTROINTESTINAL HAEMORRHAGE 76 0.0103
425 END STAGE RENAL DISEASE 187 0.0102
426 TOOTH INFECTION 135 0.0102
427 RASH ERYTHEMATOUS 489 0.0102
428 INFUSION SITE ERYTHEMA 86 0.0102
429 ELECTROLYTE IMBALANCE 118 0.0101
430 MUSCULAR WEAKNESS 1153 0.0101
431 ABDOMINAL PAIN 2349 0.0101
432 COAGULOPATHY 168 0.0101
433 SINUS TACHYCARDIA 143 0.0101
434 PRURITUS 3867 0.0101
435 DECREASED APPETITE 2328 0.0100
436 HYPERTHYROIDISM 145 0.0100
437 MYOPATHY 86 0.0099
438 ASPHYXIA 81 0.0099
439 ABDOMINAL DISTENSION 1034 0.0099
440 LYMPHOPENIA 140 0.0099
441 ASCITES 290 0.0099
442 IMMUNOSUPPRESSION 87 0.0099
443 FUNGAL INFECTION 328 0.0098
444 CHEST PAIN 1817 0.0098
445 PARAESTHESIA 1539 0.0098
446 PANCYTOPENIA 545 0.0097
447 OEDEMA PERIPHERAL 1183 0.0097
448 PHARYNGITIS STREPTOCOCCAL 105 0.0097
449 SLEEP APNOEA SYNDROME 185 0.0097
450 SCRATCH 102 0.0097
451 WEIGHT DECREASED 2695 0.0096
452 ADVERSE DRUG REACTION 867 0.0096
453 ABDOMINAL PAIN UPPER 1987 0.0096
454 OSTEOPENIA 146 0.0096
455 ASPIRATION 105 0.0096
456 PANCREATITIS 506 0.0096
457 PERIPHERAL COLDNESS 131 0.0095
458 SKIN EXFOLIATION 802 0.0095
459 URINE OUTPUT DECREASED 83 0.0095
460 LOW BIRTH WEIGHT BABY 75 0.0094
461 FEELING COLD 262 0.0094
462 CELLULITIS 474 0.0094
463 LEFT VENTRICULAR DYSFUNCTION 63 0.0094
464 GENERALISED OEDEMA 116 0.0094
465 PNEUMONIA 3007 0.0093
466 CYANOSIS 146 0.0093
467 RASH MACULO-PAPULAR 206 0.0093
468 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 95 0.0092
469 ANAL INCONTINENCE 83 0.0092
470 ORAL PAIN 206 0.0092
471 VASCULITIS 107 0.0092
472 HEPATIC CYTOLYSIS 117 0.0092
473 HYPOGAMMAGLOBULINAEMIA 60 0.0091
474 MUSCLE SPASTICITY 112 0.0091
475 MEMORY IMPAIRMENT 1249 0.0091
476 CORONAVIRUS INFECTION 60 0.0091
477 RESPIRATORY SYNCYTIAL VIRUS INFECTION 79 0.0091
478 FLANK PAIN 85 0.0091
479 CROHN'S DISEASE 62 0.0090
480 HEPATOCELLULAR INJURY 128 0.0090
481 BOWEL MOVEMENT IRREGULARITY 69 0.0090
482 EJECTION FRACTION DECREASED 140 0.0090
483 DIVERTICULUM 64 0.0090
484 HYPERCALCAEMIA 111 0.0090
485 ERYTHEMA 1839 0.0089
486 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 67 0.0089
487 HAEMATOCRIT DECREASED 176 0.0089
488 BLOOD SODIUM DECREASED 167 0.0089
489 CIRCULATORY COLLAPSE 150 0.0088
490 SKIN REACTION 124 0.0088
491 TOOTH ABSCESS 89 0.0087
492 HYPOTHERMIA 88 0.0087
493 BLOOD MAGNESIUM DECREASED 75 0.0087
494 IRON DEFICIENCY ANAEMIA 80 0.0087
495 PRODUCTIVE COUGH 413 0.0086
496 WHITE BLOOD CELL COUNT INCREASED 331 0.0086
497 BRONCHOSPASM 123 0.0086
498 PNEUMONIA BACTERIAL 79 0.0086
499 DERMATITIS CONTACT 98 0.0086
500 TRICUSPID VALVE INCOMPETENCE 68 0.0086
501 VOMITING 4019 0.0085
502 DEVICE RELATED INFECTION 131 0.0085
503 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 70 0.0085
504 ULCER 135 0.0085
505 OROPHARYNGEAL PAIN 784 0.0085
506 MALAISE 3702 0.0084
507 PLEURAL EFFUSION 513 0.0084
508 OESOPHAGITIS 92 0.0084
509 FAECES SOFT 61 0.0084
510 CYSTITIS 267 0.0084
511 RASH PUSTULAR 61 0.0084
512 CHEST DISCOMFORT 856 0.0084
513 HYPOTENSION 1673 0.0083
514 UNRESPONSIVE TO STIMULI 215 0.0083
515 SCAB 95 0.0083
516 ADVERSE EVENT 767 0.0083
517 GASTROINTESTINAL INFLAMMATION 65 0.0083
518 CHOLESTASIS 159 0.0083
519 SKIN DISORDER 276 0.0083
520 THROMBOCYTOPENIA 925 0.0083
521 PREMATURE DELIVERY 131 0.0082
522 INSOMNIA 2191 0.0082
523 BLOOD CALCIUM INCREASED 72 0.0082
524 INTESTINAL PERFORATION 92 0.0082
525 SPINAL OSTEOARTHRITIS 72 0.0082
526 BLOOD ALBUMIN DECREASED 65 0.0082
527 PAIN IN EXTREMITY 2414 0.0082
528 GOUT 147 0.0082
529 MUSCLE SPASMS 1498 0.0082
530 ERYTHEMA MULTIFORME 76 0.0081
531 PANCREATITIS ACUTE 183 0.0081
532 DEEP VEIN THROMBOSIS 529 0.0081
533 DEPRESSION 1850 0.0081
534 CARDIOMEGALY 100 0.0081
535 HAEMOPTYSIS 226 0.0081
536 CONJUNCTIVITIS 150 0.0081
537 HYPOTHYROIDISM 257 0.0080
538 RHINORRHOEA 518 0.0080
539 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 439 0.0080
540 ACUTE KIDNEY INJURY 1222 0.0080
541 SEASONAL ALLERGY 113 0.0080
542 CHILLS 926 0.0079
543 POST PROCEDURAL INFECTION 64 0.0079
544 RASH MACULAR 275 0.0079
545 HYPERTHERMIA 60 0.0079
546 HYPERKALAEMIA 275 0.0078
547 FATIGUE 6104 0.0078
548 GAIT DISTURBANCE 1493 0.0078
549 DYSPNOEA 4413 0.0078
550 GAMMA-GLUTAMYLTRANSFERASE INCREASED 172 0.0078
551 PULMONARY EMBOLISM 734 0.0077
552 PSORIASIS 1008 0.0077
553 GASTROINTESTINAL INFECTION 69 0.0077
554 PNEUMONITIS 209 0.0077
555 HYPOCALCAEMIA 145 0.0077
556 LUNG INFECTION 119 0.0077
557 PULMONARY MASS 114 0.0076
558 PYELONEPHRITIS 66 0.0076
559 THROAT TIGHTNESS 206 0.0076
560 PERICARDIAL EFFUSION 176 0.0076
561 LIP SWELLING 253 0.0076
562 HYPOGLYCAEMIA 368 0.0076
563 SECRETION DISCHARGE 95 0.0076
564 PHARYNGITIS 94 0.0076
565 ANURIA 65 0.0075
566 HEART RATE INCREASED 747 0.0075
567 OROPHARYNGEAL DISCOMFORT 68 0.0075
568 ASTHENIA 2827 0.0075
569 POLYNEUROPATHY 90 0.0075
570 STEVENS-JOHNSON SYNDROME 167 0.0075
571 THROAT IRRITATION 337 0.0075
572 SPUTUM DISCOLOURED 71 0.0075
573 DERMATITIS ALLERGIC 94 0.0075
574 EMBOLISM 62 0.0075
575 DERMATITIS ATOPIC 393 0.0074
576 TRANSFUSION 78 0.0074
577 STATUS EPILEPTICUS 84 0.0074
578 INTESTINAL OBSTRUCTION 280 0.0074
579 LABORATORY TEST ABNORMAL 219 0.0074
580 FACE OEDEMA 125 0.0074
581 NERVE COMPRESSION 68 0.0074
582 PAIN 4523 0.0074
583 SKIN HAEMORRHAGE 109 0.0073
584 BLOOD IRON DECREASED 87 0.0073
585 TRANSAMINASES INCREASED 163 0.0073
586 HYPOMAGNESAEMIA 102 0.0073
587 BLOOD PRESSURE DECREASED 485 0.0073
588 INCONTINENCE 77 0.0073
589 THERAPEUTIC RESPONSE DECREASED 441 0.0073
590 BRONCHITIS 538 0.0073
591 IMMUNODEFICIENCY 108 0.0072
592 RENAL TUBULAR NECROSIS 71 0.0072
593 HEADACHE 4534 0.0072
594 FLUSHING 729 0.0072
595 INJECTION SITE REACTION 492 0.0071
596 SINUS BRADYCARDIA 69 0.0071
597 NEUTROPHIL COUNT INCREASED 73 0.0071
598 FLUID RETENTION 362 0.0071
599 DIARRHOEA 4582 0.0071
600 SMALL INTESTINAL OBSTRUCTION 87 0.0071
601 LYMPHADENOPATHY 250 0.0071
602 SKIN ULCER 182 0.0070
603 EMPHYSEMA 71 0.0070
604 LEUKOCYTOSIS 127 0.0070
605 FOOT FRACTURE 133 0.0070
606 ILEUS 87 0.0070
607 SHOCK 161 0.0070
608 ANKLE FRACTURE 108 0.0070
609 JOINT INJURY 149 0.0070
610 ANGIOEDEMA 308 0.0070
611 TINNITUS 319 0.0069
612 PNEUMOTHORAX 109 0.0069
613 RESPIRATORY TRACT INFECTION 179 0.0069
614 METABOLIC ACIDOSIS 219 0.0068
615 CYST 85 0.0068
616 BONE MARROW FAILURE 139 0.0068
617 NEUROPATHY PERIPHERAL 650 0.0068
618 UROSEPSIS 63 0.0068
619 LEUKOPENIA 341 0.0068
620 BRAIN OEDEMA 86 0.0068
621 ANAEMIA 1294 0.0068
622 BACK PAIN 1564 0.0067
623 ALANINE AMINOTRANSFERASE INCREASED 413 0.0067
624 CHOLECYSTITIS 80 0.0067
625 GASTROENTERITIS VIRAL 121 0.0067
626 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 172 0.0067
627 FLUID OVERLOAD 97 0.0067
628 CONSTIPATION 1444 0.0066
629 BLOOD TEST ABNORMAL 93 0.0066
630 SWELLING FACE 431 0.0066
631 HEPATOTOXICITY 147 0.0066
632 PROCEDURAL PAIN 183 0.0066
633 NASAL CONGESTION 387 0.0066
634 HIDRADENITIS 60 0.0066
635 RED BLOOD CELL COUNT DECREASED 188 0.0066
636 PNEUMONIA ASPIRATION 164 0.0066
637 FOETAL EXPOSURE DURING PREGNANCY 533 0.0066
638 CYTOPENIA 80 0.0065
639 ACCIDENTAL OVERDOSE 239 0.0065
640 ASPARTATE AMINOTRANSFERASE INCREASED 347 0.0065
641 NAUSEA 5157 0.0065
642 PREMATURE BABY 196 0.0065
643 EYE DISCHARGE 67 0.0064
644 BLOOD CREATININE INCREASED 421 0.0064
645 COVID-19 PNEUMONIA 76 0.0064
646 PHOTOPHOBIA 121 0.0064
647 ORTHOSTATIC HYPOTENSION 112 0.0064
648 MICTURITION URGENCY 73 0.0064
649 DEHYDRATION 851 0.0064
650 NEPHROLITHIASIS 292 0.0064
651 COVID-19 1116 0.0064
652 PAIN IN JAW 180 0.0063
653 URINARY TRACT INFECTION 1083 0.0063
654 CHRONIC KIDNEY DISEASE 482 0.0063
655 PHARYNGEAL SWELLING 62 0.0063
656 BLOOD UREA INCREASED 106 0.0063
657 NEUTROPENIA 857 0.0063
658 HEPATIC FAILURE 190 0.0063
659 ANXIETY 1793 0.0063
660 TOOTHACHE 114 0.0063
661 DRY SKIN 840 0.0063
662 EYE INFECTION 71 0.0063
663 DIZZINESS 3131 0.0063
664 SUPRAVENTRICULAR TACHYCARDIA 60 0.0063
665 QUALITY OF LIFE DECREASED 84 0.0063
666 EYE SWELLING 232 0.0062
667 ATAXIA 74 0.0062
668 BLOOD CALCIUM DECREASED 70 0.0062
669 VERTIGO 378 0.0062
670 MYOCARDITIS 71 0.0062
671 COUGH 1737 0.0062
672 INCORRECT PRODUCT ADMINISTRATION DURATION 134 0.0062
673 BLOOD LACTATE DEHYDROGENASE INCREASED 98 0.0062
674 EYE INFLAMMATION 59 0.0062
675 PULMONARY OEDEMA 276 0.0062
676 SPINAL PAIN 72 0.0061
677 NIGHTMARE 212 0.0061
678 DRUG TOXICITY 83 0.0061
679 BASAL CELL CARCINOMA 95 0.0061
680 BRADYCARDIA 322 0.0061
681 LETHARGY 349 0.0061
682 VENTRICULAR TACHYCARDIA 100 0.0060
683 BLOOD BILIRUBIN INCREASED 163 0.0060
684 LACRIMATION INCREASED 182 0.0060
685 CARDIOMYOPATHY 89 0.0060
686 HYPOTONIA 60 0.0060
687 MUSCULOSKELETAL CHEST PAIN 93 0.0060
688 GASTRITIS 158 0.0060
689 RENAL FAILURE 797 0.0060
690 LOCALISED INFECTION 145 0.0060
691 TOOTH FRACTURE 66 0.0060
692 MENTAL STATUS CHANGES 166 0.0060
693 ANAPHYLACTIC SHOCK 154 0.0060
694 ABDOMINAL PAIN LOWER 151 0.0060
695 HYPOAESTHESIA ORAL 90 0.0060
696 RENAL FAILURE ACUTE 253 0.0060
697 TENDONITIS 92 0.0059
698 LYMPHOCYTE COUNT DECREASED 105 0.0059
699 RASH PAPULAR 133 0.0059
700 PRESYNCOPE 144 0.0059
701 GENERALISED TONIC-CLONIC SEIZURE 98 0.0059
702 UNDERDOSE 431 0.0059
703 SUBARACHNOID HAEMORRHAGE 60 0.0059
704 EYE PRURITUS 197 0.0059
705 HAEMOGLOBIN DECREASED 597 0.0058
706 DRUG INEFFECTIVE 7659 0.0058
707 SKIN DISCOLOURATION 267 0.0058
708 POOR QUALITY SLEEP 124 0.0058
709 OSTEOMYELITIS 104 0.0057
710 BLOOD ALKALINE PHOSPHATASE INCREASED 142 0.0057
711 MYOCARDIAL ISCHAEMIA 65 0.0057
712 DYSPNOEA EXERTIONAL 215 0.0057
713 KIDNEY INFECTION 112 0.0057
714 THERAPY PARTIAL RESPONDER 89 0.0057
715 HAEMORRHAGE INTRACRANIAL 85 0.0057
716 LACTIC ACIDOSIS 184 0.0057
717 DYSURIA 209 0.0057
718 PETECHIAE 59 0.0056
719 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 294 0.0056
720 POST PROCEDURAL COMPLICATION 108 0.0056
721 PALPITATIONS 658 0.0056
722 PULMONARY HYPERTENSION 117 0.0056
723 AGRANULOCYTOSIS 104 0.0056
724 NODULE 73 0.0056
725 INFLUENZA 622 0.0056
726 VISUAL IMPAIRMENT 690 0.0056
727 COLD SWEAT 98 0.0056
728 DYSPHAGIA 527 0.0055
729 CARDIAC ARREST 457 0.0055
730 BURNING SENSATION 388 0.0055
731 HEPATIC STEATOSIS 103 0.0055
732 INFLUENZA LIKE ILLNESS 452 0.0055
733 MYOCLONUS 65 0.0054
734 PHOTOSENSITIVITY REACTION 90 0.0054
735 RESTLESS LEGS SYNDROME 99 0.0054
736 HERPES ZOSTER 312 0.0054
737 DISEASE RECURRENCE 258 0.0054
738 RESPIRATORY TRACT CONGESTION 86 0.0054
739 MITRAL VALVE INCOMPETENCE 61 0.0054
740 BLOOD POTASSIUM DECREASED 162 0.0054
741 SOMNOLENCE 1084 0.0054
742 OCULAR HYPERAEMIA 255 0.0054
743 GASTROINTESTINAL PAIN 59 0.0054
744 BRAIN FOG 84 0.0054
745 PAIN OF SKIN 144 0.0053
746 RHABDOMYOLYSIS 222 0.0053
747 ILLNESS 548 0.0053
748 PULMONARY CONGESTION 70 0.0053
749 REBOUND EFFECT 60 0.0053
750 ACUTE MYOCARDIAL INFARCTION 155 0.0053
751 HIATUS HERNIA 68 0.0052
752 EOSINOPHILIA 92 0.0052
753 CAESAREAN SECTION 61 0.0052
754 SEIZURE 604 0.0052
755 TREATMENT NONCOMPLIANCE 286 0.0052
756 ALTERED STATE OF CONSCIOUSNESS 113 0.0052
757 ECONOMIC PROBLEM 79 0.0052
758 INTERNATIONAL NORMALISED RATIO INCREASED 148 0.0052
759 THYROID DISORDER 80 0.0052
760 EYELID OEDEMA 60 0.0052
761 DIABETES MELLITUS 393 0.0052
762 OSTEONECROSIS 169 0.0051
763 EYE DISORDER 169 0.0051
764 HEMIPARESIS 87 0.0051
765 NEOPLASM 59 0.0051
766 SNEEZING 115 0.0051
767 HYPOPHAGIA 131 0.0051
768 GALLBLADDER DISORDER 91 0.0051
769 NEUTROPHIL COUNT DECREASED 206 0.0050
770 INTERVERTEBRAL DISC PROTRUSION 110 0.0050
771 DRUG INTERACTION 794 0.0050
772 SINUS DISORDER 99 0.0050
773 RASH GENERALISED 129 0.0050
774 ANHEDONIA 130 0.0049
775 DRY EYE 245 0.0049
776 HAEMATEMESIS 124 0.0049
777 DISEASE PROGRESSION 576 0.0049
778 HAEMATOMA 126 0.0049
779 IMPAIRED GASTRIC EMPTYING 66 0.0048
780 INSURANCE ISSUE 74 0.0048
781 GLAUCOMA 93 0.0048
782 NERVOUS SYSTEM DISORDER 150 0.0048
783 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 112 0.0048
784 HYPERHIDROSIS 619 0.0048
785 MELAENA 105 0.0048
786 TOOTH DISORDER 106 0.0048
787 LIMB INJURY 129 0.0047
788 PROTEINURIA 90 0.0047
789 APHONIA 66 0.0047
790 URINARY INCONTINENCE 140 0.0047
791 BONE PAIN 276 0.0047
792 FLATULENCE 267 0.0047
793 BLOOD TRIGLYCERIDES INCREASED 83 0.0047
794 FEEDING DISORDER 95 0.0047
795 ACUTE MYELOID LEUKAEMIA 73 0.0047
796 EPISTAXIS 350 0.0047
797 PLATELET COUNT INCREASED 61 0.0047
798 DEPRESSED LEVEL OF CONSCIOUSNESS 185 0.0047
799 SCAR 80 0.0047
800 BONE DISORDER 85 0.0047
801 DYSGEUSIA 346 0.0047
802 DYSPHONIA 272 0.0046
803 CARPAL TUNNEL SYNDROME 65 0.0046
804 BLOOD POTASSIUM INCREASED 75 0.0046
805 RIB FRACTURE 95 0.0046
806 MYALGIA 784 0.0046
807 ACUTE HEPATIC FAILURE 63 0.0046
808 LIVER FUNCTION TEST ABNORMAL 134 0.0046
809 SYNCOPE 459 0.0046
810 BEDRIDDEN 60 0.0046
811 HERNIA 88 0.0045
812 CHOLELITHIASIS 149 0.0045
813 DIPLOPIA 118 0.0045
814 HEAD DISCOMFORT 80 0.0045
815 SINUS CONGESTION 61 0.0045
816 FAECES DISCOLOURED 97 0.0045
817 HOT FLUSH 337 0.0045
818 PLATELET COUNT DECREASED 475 0.0045
819 DIVERTICULITIS 123 0.0044
820 CORONARY ARTERY DISEASE 134 0.0044
821 RETCHING 94 0.0044
822 APHASIA 133 0.0044
823 PERITONITIS 91 0.0044
824 SPINAL FRACTURE 88 0.0044
825 DIABETIC KETOACIDOSIS 105 0.0044
826 NEOPLASM PROGRESSION 152 0.0044
827 FALL 1454 0.0044
828 MASS 61 0.0044
829 SKIN BURNING SENSATION 311 0.0043
830 LOSS OF CONSCIOUSNESS 556 0.0043
831 DYSARTHRIA 163 0.0043
832 RENAL IMPAIRMENT 363 0.0043
833 DISORIENTATION 171 0.0043
834 DRUG ERUPTION 76 0.0043
835 CATARACT 255 0.0043
836 EATING DISORDER 91 0.0043
837 GASTRIC ULCER 81 0.0043
838 CARDIO-RESPIRATORY ARREST 178 0.0043
839 THIRST 76 0.0042
840 LIMB DISCOMFORT 131 0.0042
841 PRODUCT PRESCRIBING ISSUE 92 0.0042
842 HALLUCINATION, VISUAL 88 0.0042
843 MUSCLE TWITCHING 96 0.0042
844 CHROMATURIA 94 0.0042
845 BLOOD URINE PRESENT 79 0.0042
846 ATRIAL FIBRILLATION 404 0.0041
847 POLLAKIURIA 173 0.0041
848 DRUG RESISTANCE 106 0.0041
849 URINARY RETENTION 137 0.0041
850 SKIN CANCER 88 0.0041
851 THROMBOSIS 328 0.0041
852 MUSCULOSKELETAL DISCOMFORT 70 0.0041
853 HYPERSOMNIA 116 0.0040
854 DISTURBANCE IN ATTENTION 215 0.0040
855 ISCHAEMIC STROKE 71 0.0040
856 PRURITUS GENERALISED 86 0.0040
857 ELECTROCARDIOGRAM QT PROLONGED 143 0.0040
858 DYSSTASIA 116 0.0040
859 UPPER LIMB FRACTURE 79 0.0040
860 PRODUCT ADMINISTRATION ERROR 80 0.0040
861 PRODUCT PRESCRIBING ERROR 94 0.0039
862 EYE PAIN 222 0.0039
863 PHARYNGEAL OEDEMA 60 0.0039
864 PRODUCT QUALITY ISSUE 528 0.0039
865 BLOOD PRESSURE ABNORMAL 77 0.0039
866 SPEECH DISORDER 202 0.0039
867 TREMOR 636 0.0038
868 GASTROINTESTINAL HAEMORRHAGE 319 0.0038
869 HAEMORRHAGE 399 0.0038
870 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0038
871 FULL BLOOD COUNT DECREASED 76 0.0038
872 MOVEMENT DISORDER 121 0.0038
873 HEAD INJURY 119 0.0038
874 CEREBRAL HAEMORRHAGE 133 0.0037
875 INTENTIONAL PRODUCT MISUSE 324 0.0037
876 RESPIRATORY ARREST 102 0.0037
877 HEPATIC FUNCTION ABNORMAL 138 0.0037
878 MIDDLE INSOMNIA 69 0.0037
879 AGITATION 269 0.0037
880 RESTLESSNESS 133 0.0036
881 CARDIAC FAILURE 291 0.0036
882 WHITE BLOOD CELL COUNT DECREASED 390 0.0036
883 HAEMATURIA 123 0.0036
884 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
885 MENTAL DISORDER 156 0.0036
886 INTENTIONAL DOSE OMISSION 102 0.0036
887 PRODUCT DOSE OMISSION IN ERROR 101 0.0036
888 VISION BLURRED 487 0.0035
889 SKIN IRRITATION 162 0.0035
890 INCORRECT DOSE ADMINISTERED 807 0.0035
891 JAUNDICE 95 0.0035
892 DEPRESSED MOOD 186 0.0035
893 THINKING ABNORMAL 65 0.0035
894 PSYCHOTIC DISORDER 103 0.0035
895 IRRITABILITY 208 0.0035
896 MALIGNANT NEOPLASM PROGRESSION 352 0.0034
897 CHOKING 67 0.0034
898 BLINDNESS 137 0.0034
899 PELVIC PAIN 61 0.0034
900 BALANCE DISORDER 286 0.0033
901 INCREASED APPETITE 62 0.0032
902 SEROTONIN SYNDROME 62 0.0032
903 PRODUCT DOSE OMISSION ISSUE 941 0.0032
904 PANIC ATTACK 116 0.0032
905 INTERSTITIAL LUNG DISEASE 153 0.0032
906 FEELING ABNORMAL 755 0.0031
907 DEMENTIA 88 0.0031
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
909 HYPOACUSIS 133 0.0031
910 CRYING 112 0.0031
911 COMA 146 0.0031
912 AGEUSIA 76 0.0030
913 INJECTION SITE PRURITUS 204 0.0030
914 OSTEONECROSIS OF JAW 75 0.0030
915 RENAL INJURY 90 0.0030
916 CARDIAC FAILURE CONGESTIVE 242 0.0030
917 CONVULSION 172 0.0030
918 HOSPITALISATION 462 0.0030
919 ANGINA PECTORIS 86 0.0030
920 NERVOUSNESS 154 0.0029
921 HALLUCINATION 222 0.0029
922 DEAFNESS 77 0.0029
923 THERAPEUTIC RESPONSE UNEXPECTED 132 0.0029
924 CEREBROVASCULAR ACCIDENT 497 0.0029
925 MOOD SWINGS 93 0.0029
926 CEREBRAL INFARCTION 70 0.0029
927 EYE IRRITATION 164 0.0028
928 PRODUCT SUBSTITUTION ISSUE 162 0.0028
929 SURGERY 164 0.0028
930 PLASMA CELL MYELOMA 108 0.0028
931 WITHDRAWAL SYNDROME 116 0.0028
932 ACNE 208 0.0027
933 HIP FRACTURE 88 0.0027
934 ARRHYTHMIA 129 0.0027
935 AGGRESSION 136 0.0027
936 MENTAL IMPAIRMENT 65 0.0027
937 COGNITIVE DISORDER 122 0.0026
938 INJECTION SITE URTICARIA 64 0.0026
939 MOOD ALTERED 70 0.0026
940 DYSKINESIA 104 0.0026
941 DEVICE DISLOCATION 110 0.0025
942 OVERDOSE 539 0.0025
943 INJECTION SITE RASH 74 0.0024
944 BONE DENSITY DECREASED 75 0.0024
945 BLOOD GLUCOSE DECREASED 114 0.0024
946 APPLICATION SITE ERYTHEMA 62 0.0024
947 RENAL DISORDER 110 0.0024
948 FEMUR FRACTURE 72 0.0023
949 NEOPLASM MALIGNANT 154 0.0023
950 GASTRIC DISORDER 79 0.0023
951 SUICIDAL IDEATION 210 0.0023
952 DEVICE BREAKAGE 93 0.0023
953 TOXICITY TO VARIOUS AGENTS 381 0.0023
954 EMOTIONAL DISTRESS 272 0.0022
955 EXPIRED PRODUCT ADMINISTERED 74 0.0022
956 ABORTION SPONTANEOUS 85 0.0021
957 ABNORMAL BEHAVIOUR 84 0.0021
958 DRUG DOSE OMISSION BY DEVICE 166 0.0021
959 EMOTIONAL DISORDER 65 0.0021
960 DRUG EXPOSURE DURING PREGNANCY 71 0.0021
961 VISUAL ACUITY REDUCED 69 0.0021
962 DEVICE LEAKAGE 89 0.0021
963 THERAPY INTERRUPTED 146 0.0020
964 MYELOSUPPRESSION 73 0.0020
965 UNEVALUABLE EVENT 152 0.0020
966 CARDIAC DISORDER 187 0.0020
967 INJECTION SITE ERYTHEMA 244 0.0020
968 INJECTION SITE SWELLING 150 0.0020
969 BLOOD GLUCOSE INCREASED 365 0.0019
970 INJECTION SITE BRUISING 152 0.0019
971 DEATH 1624 0.0019
972 PRODUCT DOSE OMISSION 119 0.0018
973 MYOCARDIAL INFARCTION 317 0.0018
974 DEVICE MALFUNCTION 120 0.0017
975 INJECTION SITE PAIN 517 0.0017
976 DRUG EFFECT DECREASED 88 0.0016
977 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 75 0.0016
978 THERAPY CESSATION 79 0.0015
979 NO ADVERSE EVENT 278 0.0015
980 DEVICE ISSUE 137 0.0015
981 MULTIPLE SCLEROSIS 69 0.0014
982 SUICIDE ATTEMPT 83 0.0014
983 DRUG DOSE OMISSION 203 0.0012
984 INTENTIONAL OVERDOSE 77 0.0012
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
986 INJECTION SITE HAEMORRHAGE 86 0.0011
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 207 0.0010
988 DRUG DEPENDENCE 152 0.0009
989 ACCIDENTAL EXPOSURE TO PRODUCT 89 0.0009
990 BREAST CANCER 77 0.0008
991 DRUG WITHDRAWAL SYNDROME 66 0.0008